抗小鼠CD25抗体（克隆号PC61, PC61.5或PC61.5.3）引用文献

抗小鼠CD25单克隆抗体（克隆号PC61, PC61.5或PC61.5.3）引用文献如下：

1. Two novel human anti-CD25 antibodies with antitumor activity inversely related to their affinity and in vitro activity
2. TRAIL suppresses tumor growth in mice by inducing tumor-infiltrating CD4+CD25+ Treg apoptosis
3. A distinct subpopulation of CD25− T-follicular regulatory cells localizes in the germinal centers
4. IL-2 can signal via chemokine receptors to promote regulatory T cells’ suppressive function
5. Mast cells suppress murine GVHD in a mechanism independent of CD4+CD25+ regulatory T cells
6. T cell mediated immunity after combination therapy with intralesional PV-10 and blockade of the PD-1/PD-L1 pathway in a murine melanoma model
7. Potent antitumour activity of interleukin-2-Fc fusion proteins requires Fc-mediated depletion of regulatory T-cells
8. TGF-β3-expressing CD4+CD25−LAG3+ regulatory T cells control humoral immune responses
9. Low-Zone IL-2 Signaling: Fusion Proteins Containing Linked CD25 and IL-2 Domains Sustain Tolerogenic Vaccination in vivo and Promote Dominance of FOXP3+ Tregs in vitro
10. Proenkephalin+ regulatory T cells expanded by ultraviolet B exposure maintain skin homeostasis with a healing function
……

Syd Labs抗小鼠CD25重组抗体（克隆号PC61, PC61.5或PC61.5.3）：

Syd Labs 重组抗小鼠CD25单克隆抗体，大鼠IgG1 Lamda，体内实验级（In vivo Grade Recombinant Anti-mouse CD25 Monoclonal Antibody, Rat IgG1 Lambda，货号：PA007156.rt1）是用CHO细胞生产的重组抗体，适用于体外和体内研究，包括免疫沉淀(IP)、免疫组织化学(IHC)、流式细胞术(FC)和各种功能分析，如体内清除CD25+CD4+ 调节性T细胞，体外阻断IL-2与低亲和力和高亲和力受体的结合，以及抑制依赖IL-2的T细胞系的生长等。

如果需要了解更多有关Syd Labs 重组抗小鼠CD25抗体(克隆号PC61, PC61.5或PC61.5.3)信息，比如Syd Labs 抗小鼠CD25重组抗体使用说明等资料，欢迎联系多找找获取。

特此声明：多找找推广的所有产品和服务的价格、货期和规格等信息如有更改，恕不另行通知。除非另有说明，多找找推广的所有目录和定制产品仅限于科研使用，不得用于人类或动物的诊断或治疗。